The US Government awards $55B+ annually to Life Sciences organizations for R&D and procurement of drugs, biologicals, and medical devices. These awards provide an alternate source of non-dilutive financing for start-up biotech and life sciences organizations focused on R&D.
The presentations will provide an introduction to US Government contracting for Life Sciences companies. Attendees will leave with a basic understanding of what type of technology/innovations/R&D priorities are of interest to the US Government, how to identify opportunities and win awards, the associated risks and benefits of USG-funded programs, and the key attributes of a successful USG contractor.